Triple-negative breast cancer (TNBC) is characterized by an absence of estrogen receptor (ER−), and progesterone receptor (PR−) expression, and also lacking overexpression of the HER2 epidermal growth factor receptor (HER2−). The gene discussed is PGR; the disease is triple-negative breast carcinoma.